[Severe candidal balanoposthitis on concurrent treatment with secukinumab and the antidiabetic agent empagliflozin (sodium-glucose cotransporter 2 inhibitor-SGLT2-inhibitor)]: reply - Lang, Nina; Happle, Rudolf; Hänßle, Holger (Journal der Deutschen Dermatologischen Gesellschaft, 2019)
Gesehen am 18.10.2019